Recently, at the 4th Jiangbei Water City Vascular Surgery conference, the launch meeting of the Falspeed® PTA balloon dilatation catheter was held.

Marketing Director of Kossel Medtech Eva Pan said: The Falspeed® PTA balloon catheter as Kossel first peripheral product, was approved by the NMPA in June. Kossel Medtech peripheral field is subdivided into three areas: peripheral veins, arteries and embolism. The development and progress of domestic medical devices cannot be separated from the accumulation of clinical experience, the upgrading of raw materials, the gradual refinement of the manufacturing process, and the training of talents. It is believed that in the future, domestic enterprises will surely let the world see that “Made in China” in this subdivided field of medical devices will bring “product confidence” to Chinese people, better serve human health and benefit more patients.

Professor Xuejun Wu said: The Falspeed® PTA balloon dilatation catheter has a super-lubricity hydrophilic coating and excellent material, which ensures its non-compliance. In addition, the process has a great impact on the user experience. The excellent withdrawal performance is not only the depends on raw material but is also related to the high precision process. In the future, Kossel Medtech will continue to release more excellent products for clinical practice.

PTA balloon catheter also is under-registered with FDA and is expected to get the 510(K) clearance by the end of 2022. Looking forward to what will soon hit the global market! Please inquire freely to get more innovative details!